Oncopeptides CFO Anders Martin-Löf will present at Aktiespararna's event Aktiedagen Stockholm on May 4 at 13:30 CET. The share day is broadcast live from 07: 50-20: 00 CET and 18 listed companies participate.
Welcome to listen to the presentation via the link below.
January 21, 2022, Oncopeptides announced that the Company has contacted the US Food and Drug Administration and rescinded the October 22, 2021, letter requesting voluntary withdrawal of the NDA of Pepaxto® in the US.
Investors, financial analysts and media are invited to participate in a webcast with a Q&A session on January 24, 2022, at 09:00 (CET).